Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
How do you define the suprapubic volume for adjuvant penile cancer treatment?
Related Questions
Is there a role for prostate cancer lesion boost with EBRT in the setting of combination EBRT+ brachytherapy?
For patients undergoing bladder preservation therapy with TMT, how do you manage the urinary urgency and frequency during and after treatment?
Would you offer prostate SBRT to a patient on a TKI?
Does a negative staging PSMA PET in a patient with biopsy-proven recurrent prostatic adenocarcinoma change your management?
Do you advise Kegels/pelvic floor physical therapy to minimize urinary incontinence when irradiating the prostatic fossa?
Which patients do you consider to be good candidates for salvage local treatment after radiation therapy?
Is there an SIB boost regimen for a dominant prostate lesion for 60 Gy/20 fx to the whole prostate?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
How would you treat high risk prostate cancer in a patient with autonomic bladder dysfunction?
Do you dose escalate a patient with high risk prostate cancer who refuses ADT due to potential side effects?
